Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside
Open Access
- 1 June 2014
- journal article
- review article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 20 (s6), 54-59
- https://doi.org/10.1111/1469-0691.12495
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)Antimicrobial Agents and Chemotherapy, 2013
- ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic proceduresClinical Microbiology & Infection, 2012
- EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)Clinical Microbiology & Infection, 2012
- Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteriaDiagnostic Microbiology and Infectious Disease, 2011
- Detection and investigation of invasive mould diseaseJournal of Antimicrobial Chemotherapy, 2010
- Comparison of antifungal MICs for yeasts obtained using the EU-CAST method in a reference laboratory and the Etest in nine different hospital laboratoriesClinical Microbiology & Infection, 2010
- The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agentsin vitroExpert Review of Anti-infective Therapy, 2010
- EUCAST breakpoints for antifungalsDrug News & Perspectives, 2010
- Antifungal drug resistance: do molecular methods provide a way forward?Current Opinion in Infectious Diseases, 2009
- Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility TestingClinical Microbiology Reviews, 2006